Drug Profile
NGX 6320
Latest Information Update: 21 Nov 2006
Price :
$50
*
At a glance
- Originator NeurogesX
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 21 Nov 2006 Discontinued - Preclinical for Neuropathic pain in USA (unspecified route)
- 11 Mar 2002 Preclinical trials in Neuropathic pain in USA (unspecified route)